219 related articles for article (PubMed ID: 17308979)
41. A new strategy for constructing in vitro replication-competent 1.3 copies of hepatitis B virus genome.
Hu JL; Cui J; Deng XY; Zhang WL; Li QL; Guo JJ; Zeng AZ; Huang AL
J Virol Methods; 2009 Oct; 161(1):63-9. PubMed ID: 19481116
[TBL] [Abstract][Full Text] [Related]
42. [Transfection of siRNA expressing plasmids targeting S gene inhibits replication and expression of hepatitis B virus in hepatic cancer cells].
Bian ZQ; Cui ZL; Chen WZ; Liu MQ; Yan WY; Zheng ZX
Zhonghua Yi Xue Za Zhi; 2009 Feb; 89(5):347-51. PubMed ID: 19563716
[TBL] [Abstract][Full Text] [Related]
43. [Approach to transforming hepatitis B virus as a gene therapeutic vector].
Han JQ; Hu DR; Hu XL; Sun DX; Fan GR; Liu CY; Wu YP
Zhonghua Gan Zang Bing Za Zhi; 2003 Jun; 11(6):344-6. PubMed ID: 12837212
[TBL] [Abstract][Full Text] [Related]
44. Modulation of hepatitis B virus replication by expression of polymerase-surface fusion protein through splicing: implications for viral persistence.
Park GS; Kim HY; Shin HS; Park S; Shin HJ; Kim K
Virus Res; 2008 Sep; 136(1-2):166-74. PubMed ID: 18562032
[TBL] [Abstract][Full Text] [Related]
45. Inhibitory effect of the combination of CpG-induced cytokines with lamivudine against hepatitis B virus replication in vitro.
Vincent IE; Lucifora J; Durantel D; Hantz O; Chemin I; Zoulim F; Trepo C
Antivir Ther; 2009; 14(1):131-5. PubMed ID: 19320247
[TBL] [Abstract][Full Text] [Related]
46. [Study on inhibitory effect of CpG-ODN on HBV replication in vitro].
Li N; Fan XG; Chen ZH; Zhu C
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2005 Jan; 21(1):103-5. PubMed ID: 15629096
[TBL] [Abstract][Full Text] [Related]
47. Involvement of mitochondrial permeability transition in hepatitis B virus replication.
Tan C; Guo H; Zheng M; Chen Y; Huang W
Virus Res; 2009 Nov; 145(2):307-11. PubMed ID: 19682511
[TBL] [Abstract][Full Text] [Related]
48. HSPB1 is an intracellular antiviral factor against hepatitis B virus.
Tong SW; Yang YX; Hu HD; An X; Ye F; Ren H; Li SL; Zhang DZ
J Cell Biochem; 2013 Jan; 114(1):162-73. PubMed ID: 22887120
[TBL] [Abstract][Full Text] [Related]
49. Inhibition of hepatitis B virus replication by recombinant small interfering RNAs.
Wu K; Gong Y; Zhang X; Zhang Y; Mu Y; Liu F; Song D; Zhu Y; Wu J
Acta Virol; 2005; 49(4):235-41. PubMed ID: 16402680
[TBL] [Abstract][Full Text] [Related]
50. Antiviral effect of Curcuma longa Linn extract against hepatitis B virus replication.
Kim HJ; Yoo HS; Kim JC; Park CS; Choi MS; Kim M; Choi H; Min JS; Kim YS; Yoon SW; Ahn JK
J Ethnopharmacol; 2009 Jul; 124(2):189-96. PubMed ID: 19409970
[TBL] [Abstract][Full Text] [Related]
51. Control of HBV replication by antiviral microRNAs transferred by lentiviral vectors for potential cell and gene therapy approaches.
Kumar M; Follenzi A; Garforth S; Gupta S
Antivir Ther; 2012; 17(3):519-28. PubMed ID: 22300804
[TBL] [Abstract][Full Text] [Related]
52. Human bone marrow mesenchymal stem cells are resistant to HBV infection during differentiation into hepatocytes in vivo and in vitro.
Xie C; Zheng YB; Zhu HP; Peng L; Gao ZL
Cell Biol Int; 2009 Apr; 33(4):493-500. PubMed ID: 19272332
[TBL] [Abstract][Full Text] [Related]
53. Hepatitis B virus enhances transduction of human hepatocytes by SV40-based vectors.
Arad U; Axelrod J; Ben-nun-Shaul O; Oppenheim A; Galun E
J Hepatol; 2004 Mar; 40(3):520-6. PubMed ID: 15123369
[TBL] [Abstract][Full Text] [Related]
54. Fibronectin is essential for hepatitis B virus propagation in vitro: may be a potential cellular target?
Yang J; Ding X; Zhang Y; Bo X; Zhang M; Wang S
Biochem Biophys Res Commun; 2006 Jun; 344(3):757-64. PubMed ID: 16631116
[TBL] [Abstract][Full Text] [Related]
55. [Effects of ciclosporin and tacrolimus on replication of hepatitis B virus in vitro: a comparative study].
Xia WL; Xie HY; Shen Y; Wu LM; Zhang F; Zheng SS
Zhonghua Yi Xue Za Zhi; 2006 Jan; 86(2):111-5. PubMed ID: 16620716
[TBL] [Abstract][Full Text] [Related]
56. Inhibition of hepatitis B virus (HBV) by LNA-mediated nuclear interference with HBV DNA transcription.
Sun Z; Xiang W; Guo Y; Chen Z; Liu W; Lu D
Biochem Biophys Res Commun; 2011 Jun; 409(3):430-5. PubMed ID: 21596023
[TBL] [Abstract][Full Text] [Related]
57. Adsorption and penetration of hepatitis B virus in a nonpermissive cell line.
Qiao M; Macnaughton TB; Gowans EJ
Virology; 1994 Jun; 201(2):356-63. PubMed ID: 8184545
[TBL] [Abstract][Full Text] [Related]
58. [On the role of liver-enriched transcription factors in regulating HBV transcription and replication].
Wang S; Tang H; He F; Liu L; Huang FJ; Zhou TY; Zhao LS
Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Jan; 37(1):35-9. PubMed ID: 16468637
[TBL] [Abstract][Full Text] [Related]
59. [Establishment of a stable cell line replicating hepatitis B virus DNA carrying the reverse transcriptase region derived from a clinical isolate].
Xiang MQ; Cai XF; Zhang WL; Huang AL; Hu JL
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2013 Feb; 35(1):13-8. PubMed ID: 23469784
[TBL] [Abstract][Full Text] [Related]
60. [Stable cell line for secretion of replication-defective hepatitis B virus vector expressing blasticidin resistant gene].
Liu JX; Sun DX; Cao ZC
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2009 Aug; 23(4):316-8. PubMed ID: 20108785
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
